In other countries
The same active substances on other registers, the same brand first.
- VegzelmaCanada · 100 MG / 4 ML · Solution · Celltrion INC.Same brand
- VegzelmaCanada · 400 MG / 16 ML · Solution · Celltrion INC.Same brand
- Vegzelma 25 MG/ML Concentrado Para Solucion Para PerfusionSpain · 100 mg · concentrado para solución para perfusión · Celltrion Healthcare Hungary Kft.Same brand
- VegzelmaEuropean Union · Celltrion Healthcare Hungary Kft.Same brand
- VegzelmaCroatiaSame brand
- VegzelmaItaly · Concentrato per soluzione per infusione · Celltrion Healthcare Hungary KFTSame brand
- Vegzelma 25 mg/ml concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Celltrion Healthcare Hungary Kft.Same brand
- Vegzelma 25 mg/ml concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Celltrion Healthcare Hungary Kft.Same brand
- VegzelmaNew Zealand · Inj 25 mg per ml, 16 ml vialSame brand
- VegzelmaNew Zealand · Inj 25 mg per ml, 4 ml vialSame brand
- Vegzelma Concentrate for Solution for Infusion 25 MG/MLSingapore · 25 mg/ml · infusion, solution concentrate · Celltrion Healthcare Singapore Private LimitedSame brand
- VegzelmaUnited States · 100MG/4ML, 400MG/16ML · injectable · CelltrionSame brand
- AbevmyEuropean Union · Biosimilar Collaborations Ireland LimitedSame form
- AlymsysEuropean Union · Mabxience Research SLSame form
- AbevmyCroatiaSame form
- AlymsysCroatiaSame form
- AVASTIN 25mg/mlRomania · 25mg/ml · conc. pt. sol. perf. · Roche Registration GMBHSame form
- MVASI 25mg/mlRomania · 25mg/ml · conc. pt. sol. perf. · Amgen Technology (Ireland) UcSame form
- MvasiSaudi Arabia · Amgen Europe B.V.Same form
- MvasiSaudi Arabia · Amgen Europe B.V.Same form
- ZirabevSaudi Arabia · PfizerSame form
- AbevmyTaiwan · 注射液劑 · 台灣生資科技股份有限公司Same form
- Alymsys concentrate for solution for InfusionTaiwan · 注射劑 · 美時化學製藥股份有限公司Same form
- LumiereArgentina · 5 MG/ 0,2 ML · solución inyectable · Laboratorio Elea - Phoenix S.A.Same substance
- AbevmyCanada · 400 MG / 16 ML · Solution · Biocon Biologics Canada INCSame substance
- Abevmy 25 MG/ML Concentrado Para Solucion Para PerfusionSpain · 25 mg/ml · concentrado para solución para perfusión · Biosimilar Collaborations Ireland LimitedSame substance
- Alymsys 25 MG/ML Concentrado Para Solucion Para PerfusionSpain · 25 mg/ml · concentrado para solución para perfusión · Mabxience Research S.L.Same substance
- AbevmyItaly · Concentrato per soluzione per infusione · Biosimilar Collaborations Ireland LimitedSame substance
- AlymsysItaly · Concentrato per soluzione per infusione · Mabxience Research SLSame substance
- Abevmy 25 mg/ml concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Biosimilar Collaborations Ireland LimitedSame substance
- AnyNew Zealand · Inj 25 mg per ml, 16 ml vialSame substance
- Alymsys®Serbia · 400mg/16mL · koncentrat za rastvor za infuziju · Zentiva Pharma D.O.O.Same substance
- Alymsys®Serbia · 100mg/4mL · koncentrat za rastvor za infuziju · Zentiva Pharma D.O.O.Same substance
- Avastin®Serbia · 400mg/16mL · koncentrat za rastvor za infuziju · Roche DOO BeogradSame substance
- Abevmy™ Concentrate for Solution for Infusion 25MG/MLSingapore · 25 mg/ml · injection, solution, concentrate · Cedar Pharmaceuticals Pte. LTD.Same substance
- AVAMAB Concentrate for Solution for Infusion 100mg/4mLSingapore · 100mg/4ml · infusion, solution concentrate · Innogene Kalbiotech Pte. LTD.Same substance
- AlymsysUnited States · 100MG/4ML(25MG/ML, 400MG/16ML(25MG/ML · injectable · Amneal Pharms LLCSame substance
- JobevneUnited States · 100MG/4ML, 400MG/16ML · injectable · Biocon Biologics INCSame substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Anvisa, Brazil
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Bevacizumab
- Register
- Brazil (Anvisa)
- Status
- Authorised
- Status in the register
- Ativo
- Authorised
- 4 Mar 2024
- Registration
- 192160005
- Marketing authorisation holder
- Celltrion Healthcare Distribuicao de Produtos Farmaceuticos Dos Brasil Ltda
- ATC code
- L01XC07
- Procedure
- Registered